Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

LivePerson Q4 Sales $122.48M Miss $126.96M Estimate

LivePerson (NASDAQ:LPSN) reported quarterly sales of $122.48 million which missed the analyst consensus estimate of $126.96 million by 3.53 percent. This is a 1.07 percent decrease over sales of $123.80 million the same
byMichael Horton
March 15, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

LivePerson (NASDAQ:LPSN) reported quarterly sales of $122.48 million which missed the analyst consensus estimate of $126.96 million by 3.53 percent. This is a 1.07 percent decrease over sales of $123.80 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

NeuroBo Pharmaceuticals Announces Acceptance Of Two General Posters And One ePoster Theater Discussion Of Its Novel GLP1R And GCGR Dual Agonist, DA-1726, At The American Diabetes Association 83rd Scientific Sessions

By Benzinga Newsdesk
June 13, 8:05 AM
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced that data on DA-1726, a novel oxyntomodulin (OXM) analogue functioning

NRBO